» Articles » PMID: 23109101

Anti-infective Properties of Bacteriocins: an Update

Overview
Publisher Springer
Specialty Biology
Date 2012 Oct 31
PMID 23109101
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteriocin production is a widespread phenomenon among bacteria. Bacteriocins hold great promise for the treatment of diseases caused by pathogenic bacteria and could be used in the future as alternatives to existing antibiotics. The anti-infective potential of bacteriocins for inhibiting pathogens has been shown in various food matrices including cheese, meat, and vegetables. However, their inhibition of pathogens in vivo remains unclear and needs more investigation, due mainly to difficulties associated with demonstrating their health benefits. Many bacteriocins produced by established or potential probiotic organisms have been evaluated as potential therapeutic agents and interesting findings have been documented in vitro as well as in a few in vivo studies. Some recent in vivo studies point to the efficacy of bacteriocin-based treatments of human and animal infections. While further investigation remains necessary before the possibilities for bacteriocins in clinical practice can be described more fully, this review provides an overview of their potential applications to human and veterinary health.

Citing Articles

The microbiota: a crucial mediator in gut homeostasis and colonization resistance.

Chen Y, Xiao L, Zhou M, Zhang H Front Microbiol. 2024; 15:1417864.

PMID: 39165572 PMC: 11333231. DOI: 10.3389/fmicb.2024.1417864.


Biosynthesis, classification, properties, and applications of bacteriocins.

Singh J, Devi P, Reddy G, Jaiswal A, Kavitake D, Shetty P Front Microbiol. 2024; 15:1406904.

PMID: 38939182 PMC: 11210197. DOI: 10.3389/fmicb.2024.1406904.


Identification and Safety Assessment of KB1733 Isolated from Traditional Japanese Pickle Based on Whole-Genome Sequencing Analysis and Preclinical Toxicity Studies.

Satomi S, Takahashi S, Inoue T, Taniguchi M, Sugi M, Natsume M Microorganisms. 2024; 12(5).

PMID: 38792783 PMC: 11123836. DOI: 10.3390/microorganisms12050953.


Bacterial interactions on nutrient-rich surfaces in the gut lumen.

Chiang B, Vega G, Dunwoody S, Patnode M Infect Immun. 2024; 92(9):e0048023.

PMID: 38506518 PMC: 11384750. DOI: 10.1128/iai.00480-23.


Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria.

Lennard P, Hiemstra P, Nibbering P Antibiotics (Basel). 2023; 12(10).

PMID: 37887219 PMC: 10604037. DOI: 10.3390/antibiotics12101518.


References
1.
Svetoch E, Eruslanov B, Perelygin V, Mitsevich E, Mitsevich I, Borzenkov V . Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin. J Agric Food Chem. 2008; 56(6):1942-8. DOI: 10.1021/jf073284g. View

2.
Klaenhammer T . Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev. 1993; 12(1-3):39-85. DOI: 10.1111/j.1574-6976.1993.tb00012.x. View

3.
Gillor O, Kirkup B, Riley M . Colicins and microcins: the next generation antimicrobials. Adv Appl Microbiol. 2004; 54:129-46. DOI: 10.1016/S0065-2164(04)54005-4. View

4.
Al-Mahrous M, Jack R, Sandiford S, Tagg J, Beatson S, Upton M . Identification of a haemolysin-like peptide with antibacterial activity using the draft genome sequence of Staphylococcus epidermidis strain A487. FEMS Immunol Med Microbiol. 2011; 62(3):273-82. DOI: 10.1111/j.1574-695X.2011.00811.x. View

5.
Lamont R, Sobel J, Akins R, Hassan S, Chaiworapongsa T, Kusanovic J . The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011; 118(5):533-49. PMC: 3055920. DOI: 10.1111/j.1471-0528.2010.02840.x. View